MilliporeSigma, a subsidiary of Merck KGaA, is a leading life science and technology company that operates in the Basic & Diversified Chemicals sector. The company has a global presence, with operations in more than 60 countries and employs over 57,000 people worldwide. MilliporeSigma is committed to sustainability and has set ambitious goals to reduce its environmental impact, including decarbonisation and increasing the use of renewable energy.
Decarbonisation is a key priority for MilliporeSigma, and the company has set a target to reduce its greenhouse gas emissions by 30% by 2025, compared to 2015 levels. To achieve this, the company is implementing a range of measures, including energy efficiency improvements, the use of renewable energy, and the adoption of low-carbon technologies. MilliporeSigma has also committed to sourcing 100% renewable electricity for its global operations by 2030.
Corporate energy is another area of focus for MilliporeSigma. The company is committed to reducing its energy consumption and increasing the efficiency of its operations. To achieve this, MilliporeSigma has implemented a range of energy-saving measures, including the use of energy-efficient lighting, heating, and cooling systems, and the installation of energy-efficient equipment. The company has also implemented an energy management system to monitor and control energy use across its operations.
Corporate power purchase agreements (PPAs) are an important tool for companies looking to increase their use of renewable energy. MilliporeSigma has signed several corporate PPAs to support its renewable energy goals. In 2019, the company signed a 10-year virtual PPA with Enel Green Power North America for the purchase of 60 MW of renewable energy from the Azure Sky Wind project in Texas. The PPA will enable MilliporeSigma to offset 100% of the electricity consumption at its US manufacturing sites.
Renewable energy is a key focus for MilliporeSigma, and the company is committed to sourcing 100% renewable electricity for its global operations by 2030. The company has already made significant progress towards this goal, with 50% of its electricity consumption coming from renewable sources in 2020. MilliporeSigma has also invested in on-site renewable energy generation, including the installation of solar panels at its manufacturing sites in Massachusetts and New Jersey.
In addition to its renewable energy efforts, MilliporeSigma is also committed to reducing its water consumption and waste generation. The company has set a target to reduce its water consumption by 15% by 2025, compared to 2015 levels. To achieve this, MilliporeSigma is implementing a range of water-saving measures, including the use of water-efficient equipment and the implementation of water recycling systems. The company is also committed to reducing its waste generation and increasing its recycling rates.
MilliporeSigma's commitment to sustainability extends beyond its own operations. The company is also working with its suppliers to promote sustainable practices throughout its supply chain. MilliporeSigma has developed a supplier sustainability program to assess and improve the sustainability performance of its suppliers. The program includes a range of initiatives, including training and capacity building, supplier audits, and the development of sustainability metrics.
In conclusion, MilliporeSigma is a leading life science and technology company that is committed to sustainability. The company has set ambitious goals to reduce its environmental impact, including decarbonisation, corporate energy, corporate PPA, and renewable energy. MilliporeSigma's efforts to increase the use of renewable energy, reduce its water consumption and waste generation, and promote sustainable practices throughout its supply chain demonstrate its commitment to sustainability and its leadership in the Basic & Diversified Chemicals sector.